The series A was co-led by IQ Capital and Molten Ventures. (Getty Images) British medtech startup IMU Biosciences has landed a £40 million ($53 million) series A as it looks to move immune system ...

Multiview isn't a feature you bolt on. It's an architecture decision that shapes which devices you can reach, how much you pay to operate at scale, and how much control your product team has over the ...

The fourth edition of the e4m CTV Conference is set to take place in Mumbai on June 11. The conference will bring together decision-makers and thought leaders to discuss trends that will define the ...

Scientists are learning how the brain extracts discrete words from a continuous stream of sounds. UNIDENTIFIED PERSON #1: (Speaking Japanese). SUMMERS: Unless you speak Japanese, that probably sounded ...

IMU has built the world’s largest immune dataset and can use a simple blood sample to measure over 100 million immune data points, providing precise actionable insights for patients and healthcare ...

Multilateralism is not an option but a necessity as we build back a better world with more equality and resilience, and a more sustainable world." - Secretary-General António Guterres Multilateralism, ...

IMU Biosciences announces oversubscribed financing round, bringing its Series A to over $53M as it accelerates its work to decode the immune system with unprecedented resolution and scale, to ...

The Sporting News Wed, June 10, 2026 at 4:52 PM PDT NFL Network Insider Judy Battista supplies her initial impression of New York Jets edge rusher David Bailey's participation at the team's mandatory ...

IMU Biosciences (‘IMU or the ‘Company’), a biotechnology company decoding the immune system to pioneer a paradigm shift in how we understand, diagnose and treat disease, has successfully brought its ...

New Delhi, June 4 -- Welcome to Uncut Verdict with Sneha - where trailer breakdowns come with zero filter! Cocktail 2 trailer is here and we're decoding the vibe, drama, and romance. Can it match the ...

CTV is a strong attention driver, but marketers question its ability to deliver measurable business outcomes as gaps in attribution and execution persist, leaving it between promise and proof ...